Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FK956
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,467
Award facts
- Contract value 100% obligated
- $14,467.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,467.17 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 ml pens on January 16, 2026, with a completion date of January 20, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle that extends through December 31, 2031, designed to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery of Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist used for diabetes and weight management, aligns with DLA's mission to supply specialty medications across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. This award reflects the contractor's established capability to fulfill federal procurement requirements for brand-name pharmaceutical products through open competition on the DLA's primary pharmaceutical supply vehicle.
Quick answers
Who was awarded contract SPE2DR26FK956?
SPE2DR26FK956 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FK956 worth?
The government has obligated $14,467 on SPE2DR26FK956.
Is contract SPE2DR26FK956 an order under another contract?
Yes. SPE2DR26FK956 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK956 competed?
The extent of competition for SPE2DR26FK956 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award